Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q52884561)
Watch
English
Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases.
scientific article published in October 1993
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
title
Limitations of randomized clinical trials to recognize possible advantages of combination therapies in rheumatic diseases
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
author name string
T Pincus
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
publication date
1 October 1993
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
published in
Seminars in Arthritis and Rheumatism
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
volume
23
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
issue
2 Suppl 1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
page(s)
2-10
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
cites work
The Randomized Clinical Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Controlled Studies in Clinical Cancer Research
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An additional basic science for clinical medicine: II. The limitations of randomized trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rheumatoid arthritis: disappointing long-term outcomes despite successful short-term clinical trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Azathioprine with prednisone for polymyositis. A controlled, clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prednisone and azathioprine for polymyositis: long-term followup.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Azathioprine in the treatment of systemic lupus erythematosus. A controlled study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of azathioprine, prednisone, and heparin alone or combined in treating lupus nephritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Azathioprine plus prednisone compared with prednisone alone in the treatment of systemic lupus erythematosus. Report of a prospective controlled trial in 24 patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence for the Superiority of Immunosuppressive Drugs and Prednisone over Prednisone Alone in Lupus Nephritis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term maintenance therapy with azathioprine in systemic lupus erythematosus
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Low-dose methotrexate compared with auranofin in adult rheumatoid arthritis. A thirty-six-week, double-blind trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis. 84-month update
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis. Update after a mean of 90 months
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis results of two metaanalyses
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sensitivity to change of the health assessment questionnaire (HAQ) and other clinical and health status measures in rheumatoid arthritis: results of short-term clinical trials and observational studies versus long-term observational studies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS0049-0172%2810%2980002-2
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S0049-0172(10)80002-2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
PubMed publication ID
8278816
1 reference
stated in
Europe PubMed Central
PubMed publication ID
8278816
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8278816%20AND%20SRC:MED&resulttype=core&format=json
retrieved
28 October 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit
